Guinn, B., Schuler, P., Schrezenmeier, H., Hofmann, S., Weiss, J., Bulach, C., . . . Greiner, J. (2023). A combination of the immunotherapeutic drug anti-programmed death 1 with lenalidomide enhances specific T cell immune responses against acute myeloid Leukemia cells. International journal of molecular sciences, 24(11), . https://doi.org/10.3390/ijms24119285
Chicago-Zitierstil (17. Ausg.)Guinn, Barbara, Patrick Schuler, Hubert Schrezenmeier, Susanne Hofmann, Johanna Weiss, Christiane Bulach, Marlies Götz, und Jochen Greiner. "A Combination of the Immunotherapeutic Drug Anti-programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses Against Acute Myeloid Leukemia Cells." International Journal of Molecular Sciences 24, no. 11 (2023). https://doi.org/10.3390/ijms24119285.
MLA-Zitierstil (9. Ausg.)Guinn, Barbara, et al. "A Combination of the Immunotherapeutic Drug Anti-programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses Against Acute Myeloid Leukemia Cells." International Journal of Molecular Sciences, vol. 24, no. 11, 2023, https://doi.org/10.3390/ijms24119285.